ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity. Vadla G P, Ricardez Hernandez S M, Mao J, Garro-Kacher M O, Lorson Z C, Rice R P, Hansen S A, Lorson C L, Singh K, Lorson M A. JCI Insight; Volume 8, Issue 2.
Date published:
January 24, 2023
Featured in this article:
Sara Ricardez Hernandez,
Jiude Mao,
Mona Kacher,
Christian Lorson,
Monique Lorson,
Kamlendra Singh.
Go to article...